In this issue we explore Canada’s biotech industry, a unique ecosystem reflective of the new product development pipeline where large companies partner with or invest in smaller domestic innovators. It is these partnersips and investments that are delivering gamechanging therapies for patients. In this context, Canada represents fertile territory for innovation and product development. This issue will uncover how scientists, entrepreneurs and financiers are building Canada as a place for investment and opportunity.